Changes in Mean Corpuscular Volume and RBC Distribution Width Predict Erythrocyte Engraftment Following...

Area of Science:

• Hematology
• Transplantation immunology
• Clinical laboratory science

Background:

• ABO-incompatible hematopoietic stem cell transplants (HSCT) present challenges in managing blood product support due to serologic complexities.
• Determining the optimal time to switch to donor ABO/Rh-type blood products post-HSCT is crucial for patient care.
• Existing methods for assessing erythrocyte engraftment can be complex in ABO-incompatible scenarios.

Purpose of the Study:

• To identify reliable laboratory parameters for assessing erythrocyte engraftment following ABO-incompatible HSCT.
• To establish an indicator for transitioning patients to donor ABO/Rh-type blood products post-transplant.
• To evaluate the utility of routinely measured parameters as surrogate markers for engraftment.

Main Methods:

• Explored Red Blood Cell Distribution Width (RDW), mean corpuscular volume, and hemoglobin.
• Analyzed data from 65 patients undergoing ABO/Rh-incompatible HSCT.
• Correlated laboratory parameters with the appearance of engrafted donor red blood cells (RBCs).

Main Results:

• A peak in RDW significantly correlated with the appearance of engrafted donor RBCs (P=.002).
• Serologic changes in ABO/Rh type also corresponded with a peak in RDW (P=.002).
• High RDW values likely reflect a mix of newly engrafted young erythrocytes and older recipient erythrocytes.

Conclusions:

• Peak RDW serves as a potential indicator of erythrocyte engraftment after ABO/Rh-incompatible HSCT.
• RDW offers a practical surrogate marker for monitoring engraftment and guiding transfusion support decisions.
• This finding simplifies the management of blood products post-transplant in complex ABO-incompatible cases.